Indeed, whereas it is well known that TILs are associated with better clinical outcomes in TNBC- and HER-2 positive breast cancer [51,52], the study of Desmedt, Salgado et al. described that TIL levels were associated with worse prognostic outcomes in lobular carcinoma [50]. Here, ERBB2 is linked to breast lobular carcinoma.